Nuclera
Nuclera is a biotechnology company based in Cambridge, UK, and Boston, USA, founded in 2013. It focuses on accelerating access to functional proteins for scientists, particularly in drug research, through its eProtein Discovery™ system that automates and optimizes protein expression and purification.
Finanzierungsrunden
1
Gesamtvolumen
€11.0 Mio.
Letzte Runde
Series C
Investoren
4
Finanzierung nach Stage
Finanzierungsrunden
| Stage | Betrag | Investoren | Datum |
|---|---|---|---|
| Series C | €11.0 Mio. | 14. Jan. 2026 |
